MX200VR | MonolixSuite Spring School: High-Impact Pharmacometrics Case Studies

Content
27 modules

Difficulty
Intermediate

Rating

Course length
10 hours

Instructor
Monika Twarogowska

Price
Free

Description


MonolixSuite Spring School:
High - Impact Pharmacometrics Case Studies

Beyond routine PKPD: TMDD, Oncology, conc-QTc, Biosimilars and MBMA

Free Online Training | March 23 - 27, 2026

 


Why This Training Matters

Most pharmacometric projects don’t start out as “advanced.” They become advanced the moment a standard PK model is no longer enough. When that shift happens, the questions change:

  • How do you choose the right TMDD approximation for a biologic?
  • How do you model tumor response when dropout is driven by progression rather than "missing-at-random"?
  • What makes a conc-QTc analysis workflow truly submission-ready?
  • How do regulators expect biosimilarity to be demonstrated?
  • Where do you start with MBMA across multiple trials?

These approaches—TMDD, tumor growth dynamics, conc-QTc, biosimilars, and MBMA—shape critical development decisions. Yet, they often feel intimidating or reserved for specialists.

The real challenge is rarely the equations themselves. The difficulty lies in turning a complex biological problem into a structured, interpretable, and defensible analysis. Until now, mastering these workflows has been a slow process: guidance is scattered, best practices are often learned only under project pressure, and many modelers hesitate to step into areas that seem “expert-only.”

The MonolixSuiteTM Spring School is designed to make these workflows accessible through a clear, expert-guided learning path. Across five focused case studies, you will learn complete workflows — from model building and diagnostics to simulation-based decision support and standardized reporting.

The Outcome? You will leave with:

  1. Practical strategies for non-standard data types and challenges.
  2. Reusable project workflows you can apply immediately.
  3. The confidence to tackle complex modeling questions far beyond routine PK/PD.

How You Will Learn

The MonolixSuite™ Spring School is a modular, expert-guided and interactive course, designed to help you focus on the sessions most relevant to your work while building confidence in advanced workflows.

  • Comprehensive Onboarding & Prerequisites
    A full introductory Monolix course (based on previous Spring School sessions) will be available in advance, ensuring that everyone starts with a solid foundation in MonolixSuite basics.
  • Five live online sessions led by MonolixSuite™ experts
    Learn directly from the people who develop and apply these workflows, gaining not only software instructions but insight into best practices, scientific reasoning, and real-world decision contexts.
  • Two identical 1.5-hour time slots per day + video recordings
    Choose the session time that fits your schedule, participate live, ask questions, and revisit key concepts through recordings afterwards.
  • Interactive Live Q&A and Safe Learning Environment
    Get immediate expert answers to real-time challenges. Ask the practical questions that rarely fit into tutorials: “I tried this but it didn’t work, why?”, “Is this assumption scientifically correct?”, or “How do I justify this in a report?”
  • Guided hands-on exercises with explained solutions
    Reinforce each session through practical exercises, supported by dedicated solution walk-through videos, so you can replicate the workflows independently after the course.
  • Comprehensive learning package
    Leave with a library of presentations, datasets, and reusable Monolix projects and Quarto scripts. Use these as templates to accelerate your own project work long after the course ends.

Certificate of attendance - Demonstrate your advanced thematic training in the MIDD community.

Free temporary license for all MonolixSuite™ applications - Experiment with the software during the school, apply workflows to your data, explore advanced features, and turn learning into immediate project impact.

COURSE FORUM: Connect with an international community of modelers Join a global network of pharmacometricians working on the same challenges. Exchange best practices, discuss regulatory expectations, explore future directions, and build professional connections beyond the sessions.


Skills and Insights You Will Gain

Session 1: Target-Mediated Drug Disposition (TMDD): Navigating Complexity in Biologics

TMDD is a mechanism that can fundamentally reshape a biologic’s PK, but the variety of TMDD models can be overwhelming. In this session, you will learn how to decide between full, QE/QSS, IB, or Michaelis–Menten models based on what your data actually supports. We address the primary bottleneck—parameter identifiability—and demonstrate how Simulx exploration helps to investigate which parameters can be estimated with confidence. Through expert-guided diagnosis of real mAb case studies, you will learn to ensure that parameter uncertainty remains low enough to support reliable and valuable simulations.

Session 2: Tumor Growth Inhibition (TGI): Building Defensible Models from Imperfect Data

TGI models are the backbone of oncology development, but the real challenge lies in building analyses that remain defensible when standard diagnostics look "wrong." In this session, we move beyond basic curve-fitting to explore critical strategic decisions, such as growth model selection. You will also learn to navigate the "dropout trap," where progression-driven missing data biases standard diagnostic plots, and master specific VPC bias correction techniques. Through a guided case study, you will leave with a simulation-ready workflow for optimizing doses and schedules, even when working with imperfect clinical data.

Session 3: Concentration-QTc: Automated Workflows for Regulatory Success

Building a submission-ready C-QTc assessment involves much more than fitting a single model. In this session, you will learn the standard regulatory-expected workflow for evaluating QT liability: from baseline correction and dataset preparation to model fitting and confidence interval interpretation at clinically relevant exposures. You will also discover how to automate the entire process through an R-based workflow that generates Monolix projects, key diagnostic outputs, and standardized reports. Less standard cases such as how to handle the absence of placebo data, non-linear conc-QTc relationship or hysteresis will also be covered. By the end, you will know how to deliver a complete, reproducible C-QTc assessment that meets the highest regulatory standards.

Session 4: Biosimilars: Model-Informed Strategies for Similarity Testing

Planning biosimilarity trials is challenging because true product differences are subtle, yet study outcomes are highly sensitive to inter-individual variability and design assumptions. This session explores how the FDA and EMA evaluate biosimilars and how simulations can be used to guide biosimilarity trial design decisions. Using a pegfilgrastim case study, you will see how sensitivity analyses identify the most informative dose levels and how clinical trial simulations guide sample size and power calculations. You will leave with practical tools and scientifically defensible modeling strategies to support biosimilar development programs.

Session 5: Model-Based Meta-Analysis (MBMA): Evidence Synthesis for Decision Support

MBMA allows you to benchmark a compound against competitors and predict Phase 3 performance by integrating trial-level data from literature into a single decision framework. In this session, you will learn how to model longitudinal endpoints, handle between-study and between-arm variability, and optimize parameter estimation settings. Using real-world case studies in osteoarthritis and rheumatoid arthritis, we demonstrate how MBMA supports external benchmarking by calculating the probability of trial success. This is one of the most powerful workflows for turning existing clinical evidence into strategic, forward-looking development decisions.

Certificate

By completing/passing this course, you will attain the certificate - MXSuite Attendance

1.
Welcome Video
{{ vm.helper.t('reports.module') }}
2.
2. Start Here: Practical Info and Setup
{{ vm.helper.t('reports.module') }}
3.
3. FORUM: Collaborative Discussion & Knowledge Exchange
{{ vm.helper.t('reports.module') }}
4.
4. Download and Install MonolixSuite
{{ vm.helper.t('reports.module') }}
5.
5. INTRODUCTION: Monolix
{{ vm.helper.t('reports.module') }}
6.
6. INTRODUCTION: Simulx
{{ vm.helper.t('reports.module') }}
7.
7. MATERIALS: Target-Mediated Drug Disposition: Navigating Complexity in Biologics
{{ vm.helper.t('reports.module') }}
8.
MX200VR | LIVE MEETING: Target-Mediated Drug Disposition (TMDD)
{{ vm.helper.t('events.event_component_type') }}
9.
9. HANDS-ON: Target-Mediated Drug Disposition (TMDD)
{{ vm.helper.t('reports.module') }}
10.
10. VIDEO RECORDING: Target-Mediated Drug Disposition (TMDD)
{{ vm.helper.t('reports.module') }}
11.
11. MATERIALS: Tumor Growth Inhibition (TGI): Building Defensible Models from Imperfect Data
{{ vm.helper.t('reports.module') }}
12.
MX200VR | LIVE MEETING: Tumor Growth Inhibition (TGI)
{{ vm.helper.t('events.event_component_type') }}
13.
13. HANDS-ON: Tumor Growth Inhibition
{{ vm.helper.t('reports.module') }}
14.
14. VIDEO RECORDING: Tumor Growth Inhibition (TGI)
{{ vm.helper.t('reports.module') }}
15.
15. MATERIALS: Concentration-QTc: Automated Workflows for Regulatory Success
{{ vm.helper.t('reports.module') }}
16.
MX200VR | LIVE MEETING: Concentration-QTc
{{ vm.helper.t('events.event_component_type') }}
17.
17. HANDS-ON: Concentration-QTc
{{ vm.helper.t('reports.module') }}
18.
18. VIDEO RECORDING: Concentration-QTc
{{ vm.helper.t('reports.module') }}
19.
19. MATERIALS: Biosimilars: Model-Informed Strategies for Similarity Testing
{{ vm.helper.t('reports.module') }}
20.
MX200VR | LIVE MEETING: Biosimilars
{{ vm.helper.t('events.event_component_type') }}
21.
21. HANDS-ON: Biosimilars
{{ vm.helper.t('reports.module') }}
22.
22. VIDEO RECORDING: Biosimilars
{{ vm.helper.t('reports.module') }}
23.
23. MATERIALS: Model-Based Meta-Analysis (MBMA): Evidence Synthesis for Decision Support
{{ vm.helper.t('reports.module') }}
24.
MX200VR | LIVE MEETING: Model-Based Meta-Analysis (MBMA)
{{ vm.helper.t('events.event_component_type') }}
25.
25. HANDS-ON: Model-Based Meta-Analysis
{{ vm.helper.t('reports.module') }}
26.
26. VIDEO RECORDING: Model-Based Meta-Analysis (MBMA)
{{ vm.helper.t('reports.module') }}
27.
SURVEY: MonolixSuite End-of-Course Feedback
{{ vm.helper.t('courses.survey') }}
Currently no reviews submitted

By submitting this Account Registration form, I am creating an Account and acknowledge that I have read and agreed to these Terms of Use and Learning Management System Privacy Notice. SLP Learning Management System Terms of Use

Effective: 18th March, 2024

IMPORTANT -PLEASE READ THESE TERMS OF SERVICE (THE “AGREEMENT”) CAREFULLY BEFORE ATTEMPTING TO ACCESS OR USE THE PLATFORM. THIS AGREEMENT CONSTITUTES A LEGALLY BINDING AGREEMENT BETWEEN YOU OR THE COMPANY WHICH YOU REPRESENT AND ARE AUTHORIZED TO BIND (“YOU” OR “YOUR” OR THE “END USER”), AND SIMULATIONS PLUS (“SLP” OR “WE”). THIS AGREEMENT GOVERNS YOUR USE OF THE PLATFORM AND RELATED SERVICES. BY ACCEPTING THIS AGREEMENT, YOU AGREE TO THE TERMS OF THIS AGREEMENT. If you do not agree to be bound by and comply with all the terms thereof, you SHALL not access or use our PLATFORM.

1. Definitions

For purposes of this Agreement:

1.1 “Account” means YOUR account and profile on the Platform based in information YOU submit to the Platform, and accessed using YOUR Username and Password.

1.2 “Access” Access to the platform is granted for one year after the start of any workshop. Period of access is reset each time an End User takes a paid or complimentary workshop. The one-year period provides the ability of the End User to view and track their training history after completing a workshop. This is an important feature for End Users that wish to show their current or perspective employer their qualifications and continued training efforts.

1.3 “Content” means all written, visual, electronic, audio, audio-visual content and materials that YOU access through, the Platform including all videos, pictures, photographs, text, sound clips, posts, comments, graphics, software, advice, recommendations, data, slides, images, files, links, information, chats, and any other content and materials.

1.4 “Data Protection Legislation” means all laws and regulations relating to personal data, privacy, or databases, that are applicable to the parties in connection with this Agreement. This may include without limitation: (a) General Data Protection Regulation 2016/679 (GDPR) (b) the Health Insurance Portability and Accountability Act of 1996 and its relevant regulations including the Privacy, Security, Breach Notification and Enforcement Rules (HIPAA) (c) the Family Educational Rights and Privacy Act (FERPA); (d) the Children’s Online Privacy Protection Act of 1998 (COPPA); (e) the Health Information Technology Provisions of American Recovery and Reinvestment Act of 2009 (HITECH)  (f) the California Consumer Privacy Act and its implementing regulations (g) and any other US federal or state data protection or privacy laws and regulation as may be applicable (h) any local legislation implementing or supplementing the foregoing and all associated codes of practice and other guidance issued by any applicable data protection authority, all as amended, re-enacted and/or replaced and in force from time to time.

1.5 “End User” means any individual authorized by SLP to access and use the Platform.

1.6 “Intellectual Property” or “Intellectual Property Rights” means all intellectual property rights, including all copyright, patent, trade secret, trademark, moral, termination, authorship, rights of publicity, privacy and other proprietary rights as it pertains to SLP.

1.7 “Platform” means the online learning platform services accessible through https://simulations-plus.learnupon.com/ and https://employee-simulations-plus.learnupon.com/ including all Documentation and Software in or accessible through the Platform.

1.8 “Account Start Date” means the date on which YOUR Account on the Platform is activated.

1.9 “Active Account” An Account with Paid or Complimentary Access status that has not expired or been suspended.

1.10 “Account Expiration” means the date on which YOUR Account on the Platform is deactivated, log-in disabled, but training history maintained. Access will be deactivated 12  months after start of a Workshop unless additional workshops -either Paid or Complimentary- are enrolled in by the End User during the Active Account period.

1.11 “Account Termination” means the date on which YOUR Account on the Platform is deleted, including End User history. Both Complimentary and Paid Access will be terminated 6 months after Account Expiration or permanent suspension.

2. Binding Terms and Changes

By becoming a registered user of the Platform, by clicking the "I Accept" button on the registration page, and by using the Platform, YOU acknowledge that YOU have read and understood this Agreement, and YOU agree to be bound by all of the terms and conditions of this Agreement. SLP may change the terms of this Agreement from time to time. Any changes to this Agreement will be posted on the Platform and will become effective and be binding on YOU immediately upon posting. SLP may also change the terms by notifying you by any other reasonable form of notification, effective immediately upon notice being provided. YOUR continued use of the Training following such notice constitutes YOUR acceptance of those changes.

3. Term Limit

This Agreement shall have a term commencing on the Account Start Date and ending upon the Account Termination or End User Account deletion request (“Term Limit”).

4. Use of the Platform

SLP grants to its End Users a non-transferable, non-exclusive and revocable license to the Platform for the Term Limit (Section 3) set forth in this Agreement. The Platform is solely for End User’s personal, noncommercial use; YOU may not use the Platform in any way in exchange for monetary consideration. Individuals other than the End User may not access or view electronic files or use supporting materials using the End User’s Account, whether electronically or in print. The End User is permitted online access to the Platform and may download, save, or print one hard copy of training material from the Platform solely for personal, noncommercial use.

Any violation of this Agreement or abuse of the policies provided to YOU during YOUR use of the Platform by YOU will result in the immediate and permanent cessation of access to the Platform and Account Termination, and SLP reserves the right to seek remedies for such violation available to it to the fullest extent permitted under all applicable laws, treaties, and conventions.

4.1 Use Restrictions

4.1.1 Except as expressly permitted by the terms of this Agreement, YOU shall not:

4.1.1.1 Copy, distribute, market, lease, make available, resell, make derivative works of any part of the course content available on the Platform;

4.1.1.2 Store, distribute, post, upload or transmit any Content through the Platform that is or is reasonably perceived to be infringing, unlawful or in violation of third-party privacy rights;

4.1.1.3 Introduce any virus, worm, malware, spyware, Trojan horse or other harmful or malicious code to the Platform;

4.1.1.4 Intentionally interfere with or disrupt the integrity or performance of the Platform;

4.1.1.5 Use the Platform to store or transmit sensitive personal data which could be considered special category data pursuant to the Data Protection Legislation;

4.1.1.6 Use the Platform for any illegal, unauthorized, or otherwise improper purposes.

5. Personal Information, Data Security

5.1 SLP may include the option to purchase certain products or services from SLP via the digital platform. If YOU choose to make a purchase, SLP may require sufficient information from YOU to complete the transaction.  Such information could include a credit card number and related account and billing information, invoice related information, and other data required to process the order. For services that require payment, YOU will be transferred directly to a third party for payment processing using industry standard technology. If YOU submit financial information, all of that information is submitted directly and securely to a third-party payment processor; and SLP does not retain any financial information submitted through the third-party payment processor.

5.2 YOU will be asked to submit, and consent to transfer, to SLP certain of YOUR Personal Information for YOUR Account set-up and for us to enable YOU to use the Platform.  Processing of YOUR personal information is in accordance with SLP’s Learning Services Privacy Policy found at https://www.simulations-plus.com/privacy-policy/.

5.3 The Platform is hosted by LearnUpon (learnupon.com). YOUR personal information provided to the Platform is stored by LearnUpon. For more information as to how LearnUpon uses and stores YOUR personal information, refer to ( https://www.learnupon.com/terms-of-service/)and (https://www.learnupon.com/privacy-policy/).

6. YOUR Responsibilities

6.1 Usage Limits. YOU shall not allow YOUR End User profile to be used by any other person.

6.2 Applicable Laws. YOU shall comply with all applicable laws, regulations, rules and codes with respect to activities relating in any way to YOUR use of the Platform.

7. Password Use and Security

By entering into this Agreement, YOU acknowledge that the Platform is for YOUR exclusive use only. Use or sharing of YOUR Username and Password with another user is not permitted and is cause for immediate termination of this Agreement without notice to YOU.

YOU are solely responsible for maintaining the confidentiality of YOUR Username and Password and for all activities that occur under YOUR User Name and Password. YOU agree to immediately notify SLP if YOU become aware of or have reason to believe that there is any unauthorized use of YOUR Account or any other breach of security. YOU also agree to take all reasonable steps to stop such unauthorized use and to cooperate with SLP in any investigation of such unauthorized uses or of infringements of SLP’s Intellectual Property rights in the Platform. SLP shall have the sole right, at its expense, to bring any action on account of such infringements or unauthorized uses. SLP is in no way liable for any claims related to the use or misuse of YOUR Username and Password due to the activities of any third party outside of OUR control or due to YOUR failure to maintain their confidentiality and security.

8. Cancellation, Suspension, Termination, Retention

8.1 Account deletion. YOU can request to have YOUR Account be permanently deleted from the Platform at any time. YOU can access this feature by going to YOUR profile page. If a verified Account deletion is requested by YOU, YOU will be logged out, and YOUR Account deletion will be processed in seven days, subject to the retention period noted in Section 8.4.3.

8.2 Suspension. SLP may immediately restrict or suspend (on a temporary or permanent basis) any End User’s right to access or use any portion or all of the Platform and/or to terminate and delete the End User’s Account, if SLP  reasonably determines: An End User’s use of the Platform (i) violates Section 2 (Use Restrictions), (ii) poses a security risk, (iii) violates applicable law or could subject us, our affiliates, or any third party to liability, or (iv) could be fraudulent.

8.3 Effect of Termination. Upon the effective date of Account Termination of YOUR Account, YOU shall immediately cease any further use of the Platform. It is YOUR responsibility to retain all wanted and permitted Content and to export YOUR End User training history prior to any termination of YOUR Account.

8.4 Retention.

8.4.1 Upon Account Termination, or early termination of YOUR Account by SLP (see Section 8.2), SLP initiates a process intended to safely and completely delete YOUR personal information from the Platform. Completion of this process may take up to 60 days.

8.4.2 To accommodate later access to an End User’s training history or an inadvertent Account Expiration, SLP will retain YOUR personal information on the Platform for a six-month recovery period from the date of Account Expiration, unless YOU request deletion of YOUR Account (for the latter, please see Sections 8.1, and 8.4.3) or as otherwise provided in Section 8.4.4.

8.4.3 Upon receipt of YOUR verified deletion request involving YOUR Account, SLP initiates a process intended to safely and completely delete YOUR personal information provided to the Platform from the Platform. Completion of this process may take up to 60 days.

8.4.4 Note SLP may keep YOUR personal information on the Platform for a different retention period than outlined above, for as long as necessary (i) to fulfill the purposes for which it was obtained; (ii) to meet contractual obligations; (iii) as required by a legal obligation to which SLP is subject; and (iv) to comply with applicable laws.  In some cases, SLP may choose to retain certain information (e.g., insights about use of the Platform) in a depersonalized or aggregated form.

9. Acknowledgements

SLP reserves the right (but is not required) to remove, delete and/or destroy any Content that is in breach of this Agreement.

10. Warranties, Disclaimers, Limitation on Liability

10.1 YOU warrant that (i) YOU have validly entered into this Agreement and have the legal power to do so; and (ii) that YOU will not use the Platform in violation of any applicable laws.

10.2 SLP does not guarantee that use of the Platform will be uninterrupted or error free at all times and in all circumstances, or that use of the Platform will be suitable for any particular purpose. It is YOUR responsibility to determine if the Platform meets YOUR needs for learning services.

10.3 TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW (i) SLP MAKES NO WARRANTIES OF ANY KIND WITH RESPECT TO THE PLATFORM, WHETHER EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, AND SPECIFICALLY DISCLAIMS THE IMPLIED WARRANTIES OF NONINFRINGEMENT, TITLE, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. THE PLATFORM IS PROVIDED “AS IS”; and (ii) IN NO EVENT WILL SLP BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF THIS AGREEMENT OR YOUR USE OF THE PLATFORM REGARDLESS OF THE LEGAL OR EQUITABLE THEORY (CONTRACT, TORT OR OTHERWISE) UPON WHICH THE CLAIM IS BASED. EXCEPT FOR FRAUD OR FRAUDULENT MISREPRESENTATION BY SLP, IN NO EVENT SHALL SLP’S AGGREGATE LIABILITY UNDER THIS AGREEMENT AND PROVISION OF THE PLATFORM EXCEED THE TOTAL PAYMENTS MADE BY YOU TO SLP IN RESPECT OF THE PLATFORM IN THE PRECEDING TWELVE (12) MONTHS.

10.4 Indemnification.

10.4.1 YOU shall defend  against and hold harmless SLP from any damages, fines, reasonable attorney fees and other costs incurred by or sought from SLP as a result of, or for any amounts paid by SLP under a court-approved settlement of, any claim, demand, suit, governmental action or proceeding (a “Claim”) made or brought against SLP by a third party arising out of or in connection with (i) YOUR use of the Platform in violation of these or any applicable laws, and/or (ii) YOUR breach of this Agreement.

10.4.2. SLP shall defend YOU against any claim, demand, suit, governmental action or proceeding made or brought against YOU by a third party alleging that the Content provided by SLP for YOUR use on the Platform, or use of the Platform infringes the intellectual property rights of such third party, and shall indemnify YOU for any damages, reasonable attorney fees and costs finally awarded against YOU as a result of, and for amounts paid by YOU under a court approved settlement of such claim of infringement. If such claim of infringement is made or appears likely to be made against YOU, SLP, at its option, shall have the right, at its option, to (a) procure for YOU the right to continue to use the Content subject of such claim, or replace such Content so that it is no longer infringing.

11. Governing Law.

This Agreement will be governed by the laws of the State of California without regard to the conflict of laws principles thereof.  Any dispute, controversy, or claim not resolved by a good faith discussion between YOU and SLP shall be submitted for resolution to a state or federal courts in the State of California, and YOU hereby agree to submit to the jurisdiction and venue of such courts. The Uniform Computer Information Transactions Act and the United Nations Convention on the International Sale of Goods shall not apply to this Agreement.

Shopping Cart

Your cart is empty